Preoperative capecitabine (X) chemoradiation is effective and well tolerated in patients (PTS) with locally advanced rectal cancer (LARC): findings from a phase I dose escalation study

被引：0
|
作者：
Veerasarn, V
Phromratanapongse, P
Lorvidhaya, V
Lertsanguansinchai, P
Panichchevaluk, A
Boonnuch, W
Chinswangwatanakul, V
Lahsiriwat, D
Rojanasakul, A
Thavichaigarn, P
机构：
[1] Mahidol Univ, Siriraj Hosp, Dept Radiat, Bangkok 10700, Thailand
[2] Phramongkutklao Hosp, Dept Radiat, Bangkok, Thailand
[3] Chiengmai Univ Hosp, Dept Radiat, Chiengmai, Thailand
[4] Chulalongkorn Univ, Dept Radiat, Bangkok, Thailand
[5] Rajvithi Hosp, Dept Radiat, Bangkok, Thailand
来源：
RADIOTHERAPY AND ONCOLOGY | 2004年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [1] Phase I study of preoperative chemoradiation with temozolomide and capecitabine in patients with locally advanced rectal cancer
    Hong, Yong Sang
    Park, Seong Joon
    Kim, Jeong Eun
    Kim, Kyu-Pyo
    Lee, Jae-Lyun
    Park, Jin-hong
    Kim, Jong Hoon
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Tae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Preoperative chemoradiation with nimotuzumab and capecitabine in patients with locally advanced rectal cancer: A phase II study
    Zhu, Yuan
    Liu, Luying
    Luo, Jialing
    Li, Dechuan
    Zhu, Yuping
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
    Machiels, J.
    Coche, J.
    Scalliet, P.
    Van Cutsem, E.
    Roels, S.
    Canon, J.
    Coster, B.
    Kerger, J.
    Remouchamps, V.
    Haustermans, K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 183 - 183
  • [4] Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer
    Jeong, Jae Ho
    Hong, Yong Sang
    Park, Yangsoon
    Kim, Jihun
    Kim, Jeong Eun
    Kim, Kyu-pyo
    Kim, Sun Young
    Park, Jin-hong
    Kim, Jong Hoon
    Park, In Ja
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    Kim, Tae Won
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : 289 - 295
  • [5] A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC).
    Lin, EH
    Skibber, J
    Delcos, M
    Eng, C
    Christopher, C
    Brown, T
    Vadhan, S
    Hoff, P
    Rodriguez-Bigas, M
    Janjan, NA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 269S - 269S
  • [6] Epacadostat with preoperative chemoradiation in locally advanced rectal cancer (LARC): Results of a translational phase I clinical trial
    Park, Haeseong
    Pedersen, Katrina
    Huang, Katherine
    Mutch, Matthew
    Kim, Hyun
    Trikalinos, Nikolaos
    Aranha, Olivia
    Tan, Benjamin
    Suresh, Rama
    Ratner, Lee
    Khushman, Moh'd
    Visconti, John
    Lim, Kian-Huat
    Henke, Lauren
    Swiecicki, Maddie
    Liu, Jingxia
    Parikh, Parag
    Ciorba, Matthew
    CANCER RESEARCH, 2024, 84 (07)
  • [7] Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC).
    Shi, GG
    Lin, E
    Eng, C
    Delcos, M
    Crane, C
    Amos, CB
    Brown, T
    Abbruzzese, JL
    Skibber, J
    Janjan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 312S - 312S
  • [8] Preoperative chemoradiotherapy (QT-RT) with capecitabine and oxaliplatin (CAPOX) or capecitabine alone (CAP) in patients (PTS) with locally advanced rectal cancer (LARC).
    Marrodan, Ines
    Rubio, Itziar
    Buque, Aitziber
    Sancho, Aintzane
    Fuente, Natalia
    Carrera, Sergio
    Arruti, Mikel
    Manel Mane, Joan
    Isabel Gutierrez, Eddy
    Iruarrizaga, Eluska
    Azkona, Eider
    Lopez-Vivanco, Guillermo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Socrates phase II study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (RT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    Samuel, L
    Falk, S
    Maughan, T
    McDonald, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 252S - 252S
  • [10] Preliminary phase IISOCRATES study results: Capecitabine (CAP) combined with oxaliplatin (OX) and preoperative radiation (IRT) in patients (pts) with locally advanced rectal cancer (LARC).
    Glynne-Jones, R
    Sebag-Montefiore, D
    McDonald, A
    Falk, S
    Maughan, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 263S - 263S
12345